Injection Technique11 min readUpdated 2026-04-01

    How to Rotate Injection Sites Properly

    Proper injection site rotation prevents lipohypertrophy, ensures consistent medication absorption, and reduces injection pain. Step-by-step rotation patterns for GLP-1 weekly injections.

    Weekly Rotation Advantage

    Unlike daily insulin injections that require careful rotation among many sites, GLP-1 medications are injected only once per week. This gives each injection site 7 full days to heal, making rotation simpler. Even staying within one body region (like the abdomen) works well with systematic quadrant rotation.

    Understanding Lipohypertrophy

    Lipohypertrophy is the accumulation of fatty tissue at sites of repeated injection. It occurs because insulin and insulin-like medications (including GLP-1 agonists) have local lipogenic (fat-building) effects on the subcutaneous tissue. When the same spot is used repeatedly, these effects compound, creating visible and palpable lumps.

    While lipohypertrophy is more common with daily insulin use, it can develop with weekly GLP-1 injections if the same exact spot is used every time. The clinical consequence is impaired absorption — medication injected into lipohypertrophic tissue is absorbed unpredictably, leading to inconsistent drug levels and potentially reduced efficacy.

    Prevention through proper rotation is far easier than treatment. Once lipohypertrophy develops, the affected area must be avoided for weeks to months to allow resolution. Proper technique from the start prevents this entirely.

    Rotation Pattern 1: Abdominal Quadrants

    This is the simplest and most popular rotation pattern for weekly GLP-1 injections. Divide the abdomen into four quadrants using the belly button as center. Rotate clockwise each week.

    The 4-Week Cycle

    • Week 1: Upper right abdomen
    • Week 2: Lower right abdomen
    • Week 3: Lower left abdomen
    • Week 4: Upper left abdomen
    • Week 5: Restart cycle, slightly offset from Week 1 spot

    Rules

    • Stay at least 2 inches from belly button
    • Avoid belt line and waistband areas
    • Skip areas with stretch marks or scars
    • Within each quadrant, vary the exact spot slightly

    Rotation Pattern 2: Multi-Region Rotation

    For patients who want maximum site rest, rotating between different body regions provides the longest recovery time for each area.

    3-Region Monthly Cycle

    Week 1: Right abdomen. Week 2: Left thigh. Week 3: Left abdomen. Week 4: Right thigh. This pattern uses two body regions and alternates sides, giving each specific site nearly a month to recover.

    Including the Upper Arm

    If someone can help inject your upper arm, a 6-week cycle (right abdomen, left thigh, right arm, left abdomen, right thigh, left arm) provides maximum rotation. Each site gets 6 weeks of rest between uses.

    Tracking Your Rotation

    With weekly injections, it is easy to forget where you injected last. Several strategies help maintain consistent rotation.

    Tracking Methods

    • Note in your phone calendar with each injection
    • Use a simple body diagram printout
    • Follow a fixed day-of-month pattern (e.g., 1st = upper right)
    • Use a medication tracking app with site logging

    Self-Check Monthly

    • Feel injection areas for lumps or thickening
    • Look for persistent discoloration
    • Note any areas that seem less sensitive (could indicate nerve changes)
    • Report any findings to your healthcare provider

    Special Considerations as You Lose Weight

    As you lose weight on GLP-1 therapy, your subcutaneous fat distribution changes. Areas that were previously ideal injection sites may become leaner, requiring technique adjustment. Monitor for these changes and adapt your approach.

    If abdominal fat decreases significantly, you may need to switch to a 45-degree insertion angle or transition to thigh injections where subcutaneous fat may still be adequate. Your provider can assess tissue depth and recommend appropriate adjustments during follow-up visits.

    Medical Disclaimer

    This article is for informational purposes only. Follow your healthcare provider's injection site instructions. Report any injection site changes (lumps, discoloration, persistent pain) promptly.

    Frequently Asked Questions

    Why is injection site rotation important?

    Repeated injection in the same spot causes lipohypertrophy — hard, fatty lumps under the skin that impair medication absorption. Studies show lipohypertrophy can reduce absorption by up to 25%, leading to inconsistent drug levels and reduced effectiveness. Rotation prevents this and ensures each injection absorbs properly.

    How far apart should injection sites be?

    Each injection should be at least 1 inch (2.5 cm) from the previous injection site. Within the same body region (e.g., abdomen), you can systematically move to different quadrants. Since GLP-1 injections are weekly, the previous site has 7 full days to heal before that area is used again.

    Can I always use the same body area but different spots?

    Yes, this is called 'within-area rotation' and is perfectly acceptable. Many patients prefer to always inject in the abdomen but systematically move between the four quadrants (upper right, upper left, lower right, lower left). Since there are only 4-5 injections per month, this provides adequate spacing.

    What does lipohypertrophy feel like?

    Lipohypertrophy presents as firm, rubbery, painless lumps under the skin at frequently used injection sites. They can range from small pea-sized bumps to larger areas of thickened tissue. If you notice any lumps, stop injecting in that area immediately and inform your healthcare provider. The lumps usually resolve over weeks to months once the site is rested.

    Get Expert Injection Support

    Our providers offer injection technique guidance and ongoing support.

    Consult with a Provider

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 5, 2026

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Was this article helpful?

    Keep Reading

    Compare the annual costs of GLP-1 maintenance vs active weight loss dosing. Covers brand vs compounded pricing, insurance strategies, and how dose reduction saves money.

    Navigating GLP-1 treatment during career transitions. How job changes affect insurance coverage, managing medication during interviews, and maintaining weight loss momentum.

    Scripts for communicating GLP-1 side effects effectively. How to describe symptoms, request adjustments, and advocate for yourself when side effects are impacting your life.

    When and how to start semaglutide or tirzepatide after pregnancy. Postpartum GLP-1 guide covering breastfeeding safety, timing, and realistic weight loss expectations.